Reports are indicating that some biomolecules can regulate cancer development. In this way, some data suggest that sphingosine kinases (SphK1 and SphK2) can decrease cancer cell growth through the activation of different biomolecules. It is noteworthy that several SphK1 blockers have been used to treat decreased cancer cell growth; however, their interaction with SphK1 is unclear. Therefore, the aim of this investigation was to determine the possible coupling of some flavonoid analogs (1-19) wit
No takes yet. Share an insight, caveat, or question.
Marcela et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: